Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics Price to Book Value : 16.59 for May 7, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2026 | 16.59 |
| May 06, 2026 | 16.59 |
| May 05, 2026 | 16.59 |
| May 04, 2026 | 16.59 |
| May 01, 2026 | 16.59 |
| April 30, 2026 | 16.59 |
| April 29, 2026 | 16.59 |
| April 28, 2026 | 16.59 |
| April 27, 2026 | 16.59 |
| April 24, 2026 | 16.59 |
| April 23, 2026 | 16.56 |
| April 22, 2026 | 16.56 |
| April 21, 2026 | 16.56 |
| April 20, 2026 | 16.56 |
| April 17, 2026 | 16.56 |
| April 16, 2026 | 16.54 |
| April 15, 2026 | 16.56 |
| April 14, 2026 | 16.56 |
| April 13, 2026 | 16.56 |
| April 10, 2026 | 16.56 |
| April 09, 2026 | 16.57 |
| April 08, 2026 | 16.56 |
| April 07, 2026 | 16.57 |
| April 06, 2026 | 16.54 |
| April 02, 2026 | 16.53 |
| Date | Value |
|---|---|
| April 01, 2026 | 16.53 |
| March 31, 2026 | 16.56 |
| March 30, 2026 | 16.52 |
| March 27, 2026 | 16.50 |
| March 26, 2026 | 16.52 |
| March 25, 2026 | 16.52 |
| March 24, 2026 | 16.50 |
| March 23, 2026 | 16.51 |
| March 20, 2026 | 16.52 |
| March 19, 2026 | 16.46 |
| March 18, 2026 | 16.45 |
| March 17, 2026 | 16.45 |
| March 16, 2026 | 16.45 |
| March 13, 2026 | 16.45 |
| March 12, 2026 | 16.45 |
| March 11, 2026 | 16.45 |
| March 10, 2026 | 16.44 |
| March 09, 2026 | 16.45 |
| March 06, 2026 | 16.42 |
| March 05, 2026 | 16.41 |
| March 04, 2026 | 16.41 |
| March 03, 2026 | 16.42 |
| March 02, 2026 | 16.44 |
| February 27, 2026 | 16.45 |
| February 26, 2026 | 16.41 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioMarin Pharmaceutical, Inc. | 2.009 |
| Insmed, Inc. | 35.84 |
| Ligand Pharmaceuticals, Inc. | 5.926 |
| PTC Therapeutics, Inc. | -- |
| Establishment Labs Holdings, Inc. | 99.90 |
Price to Book Value Related Metrics
| PS Ratio | 7.087 |
| Price to Free Cash Flow | 150.58 |
| Price | 14.49 |
| Earnings Yield | -0.61% |
| Market Cap | 4.550B |
| Operating PE Ratio | 130.31 |